Vaccine Adjuvants Market - Top Companies and Manufacturers

Companies Dominating the Vaccine Adjuvants Landscape

Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
GSK plc
SK Bioscience
Sanofi
Abbott
Phibro Animal Health Corporation
Astrazeneca
Novavax, Inc.
Agenus Inc.
Astellas Pharma Inc.

Browse Key Market Insights with Data Illustration:

Vaccine Adjuvants Market Size & Share, Growth Forecasts 2037

In the News

As the basis for their applications for regulatory approval, Sanofi and GSK plc intend to submit data from their booster and Phase 3 efficacy trials. The data they plan to submit is expected to include the full results of their Phase 3 efficacy trial of the vaccine, as well as data from their booster trial, which is designed to assess the efficacy of the vaccine after a booster dose.
GSK plc and SK Bioscience have submitted an application for a biologics license to the Korean Ministry of Food and Drug Safety for their SKYCovione after receiving positive Phase III clinical results. It is a candidate COVID-19 vaccine based on recombinant protein that has been adjuvant with GSK's pandemic adjuvant.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of vaccine adjuvants is evaluated at USD 2.28 billion.

The vaccine adjuvants market size was over USD 2.2 billion in 2024 and is anticipated to exceed USD 3.98 billion by the end of 2037, growing at over 4.8% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of infectious diseases and the growing demand for safe and effective vaccines will boost the market growth.

North America industry is projected to be the largest with a share of about 35% by 2037, due to large population of elderly individuals and the increasing prevalence of chronic diseases, such as cancer, diabetes, and heart disease in the region.

The major players in the market include Pfizer Inc., GSK plc, SK Bioscience, Sanofi, Abbott, Phibro Animal Health Corporation, Astrazeneca, Novavax, Inc., Agenus Inc., Astellas Pharma Inc.

Vaccine Adjuvants Market - Top Companies and Manufacturers

Companies Dominating the Vaccine Adjuvants Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the vaccine adjuvants market?

What are the factors driving the vaccine adjuvants landscape?

Which region held the largest vaccine adjuvants industry share?

Who are the key players in the vaccine adjuvants sector?